• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】51586

【品名】4-Methylimidazole; 4-Methyl-1H-imidazole; 4-Methyl Imidazole

【CA登记号】822-36-6

【 分 子 式 】C4H6N2

【 分 子 量 】82.10512

【元素组成】C 58.52% H 7.37% N 34.12%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(V)

The previously reported indanyl imidazole (I) was nitrated by means of urea nitrate in sulfuric acid to afford (II). Reduction of the nitro group of (II) to the corresponding aniline (III) was carried out by catalytic hydrogenation over PtO2. Diazotization of (III) with sodium nitrite and fluoroboric acid gave rise to the diazonium fluoroborate (IV), which was then subjected to thermal decomposition to generate the title fluoro derivative.

1 Sorbera, L.A.; Castaner, J.; Bayes, M.; Fipamezole Hydrochloride. Drugs Fut 2003, 28, 1, 14.
2 Karjalainen, A.J.; Virtanen, R.E.; Karjalainen, A.L.; Eloranta, M.M.; Salonen, J.S.; Sipilä, H.T.; Haapalinna, A.S. (Orion Corporation); Substd. imidazole derivs. and their preparation and use. EP 0618906; JP 1995506087; US 5498623; WO 9313074 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 51582 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole C14H16N2 详情 详情
(II) 51583 4-(2-ethyl-5-nitro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole C14H15N3O2 详情 详情
(III) 51584 2-ethyl-2-(1H-imidazol-4-yl)-2,3-dihydro-1H-inden-5-ylamine; 2-ethyl-2-(1H-imidazol-4-yl)-5-indanamine C14H17N3 详情 详情
(IV) 51585   C14H15BF4N4 详情 详情
(V) 51586 4-Methylimidazole; 4-Methyl-1H-imidazole; 4-Methyl Imidazole 822-36-6 C4H6N2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The alkylation of 4-methylimidazole (I) with N-(3-bromopropyl)phthalimide (II) produced a mixture of N-alkylated regioisomers (III) and (IV). After selective derivatization of the undesired 5-methyl isomer (III) with trityl chloride, the 4-methyl derivative was isolated by flash chromatography and subsequently subjected to phthaloyl group hydrazinolysis to yield amine (V). Reductive condensation of amine (V) with benzaldehyde (VI) in the presence of NaBH4 afforded the N-benzyl amine (VII).

1 Guzi, T.; Taveras, A.G.; Ferreira, J.A.; Desai, J.A.; Wang, J.J.S.; Lalwani, T.; Alvarez, C.; Afonso, A.; Girijavallabhan, V.M.; Mallams, A.K.; Doll, R.J.; Weinstein, J.; Cooper, A.B.; Chao, J.; Rane, D.F.; Aki, C.J.; Kelly, J.M. (Schering Corp.); Tricyclic farnesyl protein transferase inhibitors. EP 1140902; WO 0037459 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 51586 4-Methylimidazole; 4-Methyl-1H-imidazole; 4-Methyl Imidazole 822-36-6 C4H6N2 详情 详情
(II) 15216 N-(3-Bromopropyl)phthalimide; 2-(3-bromopropyl)-1H-isoindole-1,3(2H)-dione 5460-29-7 C11H10BrNO2 详情 详情
(III) 51587 2-[3-(5-methyl-1H-imidazol-1-yl)propyl]-1H-isoindole-1,3(2H)-dione C15H15N3O2 详情 详情
(IV) 51588 2-[3-(4-methyl-1H-imidazol-1-yl)propyl]-1H-isoindole-1,3(2H)-dione C15H15N3O2 详情 详情
(V) 51589 3-(4-methyl-1H-imidazol-1-yl)-1-propanamine; 3-(4-methyl-1H-imidazol-1-yl)propylamine C7H13N3 详情 详情
(VI) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(VII) 51590 N-benzyl-3-(4-methyl-1H-imidazol-1-yl)-1-propanamine; N-benzyl-N-[3-(4-methyl-1H-imidazol-1-yl)propyl]amine C14H19N3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XI)

Reduction of (R)-ethyl nipecotate (VII) with LiAlH4 yields 3-piperidinemethanol (VIII), which is further protected as the N-Boc derivative (IX) by using Boc2O. Treatment of the piperidine alcohol (IX) with p-toluenesulfonyl chloride and pyridine leads to tosylate (X). Condensation of the sodium derivative of 4-methylimidazole (XI) with tosylate (X) gives rise to a mixture of regioisomeric N-alkylated imidazoles, which are chromatographically separated after derivatization with trityl chloride. The desired isomer (XII) is then deprotected under acidic conditions, giving piperidine (XIII). Finally, EDC-mediated coupling between piperidine (XIII) and the piperazinecarboxylic acid (VI) furnishes the title amide.

1 Cooper, A.B.; Girijavallabhan, V.M.; Mallams, A.K.; Doll, R.J.; Kelly, J.M.; Rane, D.F.; Taveras, A.G.; Guzi, T.; Strickland, C.; Chao, J. (Schering Corp.); Farnesyl protein transferase inhibitors. EP 1140904; JP 2002533335; WO 0037458 .
2 Cooper, A.B.; Girijavallabhan, V.M.; Mallams, A.K.; Doll, R.J.; Kelly, J.M.; Rane, D.F.; Taveras, A.G.; Guzi, T.; Strickland, C.; Chao, J. (Schering Corp.); Farnesyl protein transferase inhibitors. US 6362188 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 51595 (2R)-4-[(11S)-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-[(cyclohexyloxy)carbonyl]-2-piperazinecarboxylic acid C26H30ClN3O4 详情 详情
(VII) 12453 ethyl (3R)hexahydro-3-pyridinecarboxylate C8H15NO2 详情 详情
(VIII) 57427 (1S)-2,2-dimethylcyclopropanecarbonyl chloride C6H9ClO 详情 详情
(IX) 35221 tert-butyl (3S)-3-(hydroxymethyl)-1-piperidinecarboxylate C11H21NO3 详情 详情
(X) 57428 ethyl 3-ethyl-2-pentenoate C9H16O2 详情 详情
(XI) 51586 4-Methylimidazole; 4-Methyl-1H-imidazole; 4-Methyl Imidazole 822-36-6 C4H6N2 详情 详情
(XII) 58429 tert-butyl (3S)-3-[(4-methyl-1H-imidazol-1-yl)methyl]-1-piperidinecarboxylate C15H25N3O2 详情 详情
(XIII) 58430 (3R)-3-[(4-methyl-1H-imidazol-1-yl)methyl]piperidine C10H17N3 详情 详情
Extended Information